E26* (p.Glu26Ter) variant of EIF2AK4 (eIF-2-alpha kinase GCN2)
E26* (p.Glu26Ter) in EIF2AK4 (eIF-2-alpha kinase GCN2) is a protein-truncating change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.85 / 1. The record also includes population frequency data and structural context.
E26* (p.Glu26Ter) variant details
- p.Glu26Ter
- NCI-TCGA Cosmic COSV5547
- cosmic curated COSV55475
- Variant assessed as somatic; high impact.
- Stop Gained
- Variant Prioritization Score for Impact Estimate 0.853
- CADD 41.00
- UniProt: Variant assessed as somatic; high impact.
- Population evidence available
- Structural context available